The U.S. Supreme Court has temporarily banned the ruling limiting access to abortion pills.
Justice Samuel Alito of the U.S. Supreme Court has temporarily overturned lower court decisions scheduled to take effect this weekend and would have placed temporary restrictions on the abortion drug mifepristone.
For the time being, until at least Wednesday, April 19, access to medication abortion remains unaffected. Abortion is the most frequent medical termination of pregnancy in the U.S. Currently, there is a five-day ban on restricting access or further ruling.
Danco, the company that makes the medication mifepristone, also appealed to the supreme court, citing the “regulatory turmoil” resulting from drug restrictions. In addition, the company has expressed apprehension about the possible consequence once the ruling becomes effective.
“This is a dark day for public health, especially for reproductive rights and the reliance on science and medical expertise to guide decisions about what drugs are safe and effective and should be available to patients,” says the official statement from Danco.
Mifepristone was authorized by the Food and Drug Administration (FDA) in 2000. Mifepristone, or RU-486, is relied upon heavily to induce a medical abortion during pregnancy to treat an early miscarriage.